135 related articles for article (PubMed ID: 35362545)
1. Interferon regulatory factor 5‑induced upregulation of zinc‑finger protein 217 promotes pancreatic carcinoma progression.
Qiao X; Lv S; Qiao Y; Wang F; Miao L
Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35362545
[TBL] [Abstract][Full Text] [Related]
2. The coordination between ZNF217 and LSD1 contributes to hepatocellular carcinoma progress and is negatively regulated by miR-101.
Si W; Zhao Y; Zhou J; Zhang Q; Zhang Y
Exp Cell Res; 2019 Jun; 379(1):1-10. PubMed ID: 30898548
[TBL] [Abstract][Full Text] [Related]
3. MiR-203 suppresses ZNF217 upregulation in colorectal cancer and its oncogenicity.
Li Z; Du L; Dong Z; Yang Y; Zhang X; Wang L; Li J; Zheng G; Qu A; Wang C
PLoS One; 2015; 10(1):e0116170. PubMed ID: 25621839
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA SNHG15 accelerates the progression of non-small cell lung cancer by absorbing miR-211-3p.
Ma XR; Xu YL; Qian J; Wang Y
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1536-1544. PubMed ID: 30840276
[TBL] [Abstract][Full Text] [Related]
5. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J
Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143
[No Abstract] [Full Text] [Related]
6. Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma.
Szczyrba J; Nolte E; Hart M; Döll C; Wach S; Taubert H; Keck B; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA
Int J Cancer; 2013 Feb; 132(4):775-84. PubMed ID: 22815235
[TBL] [Abstract][Full Text] [Related]
7. DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression
Xu T; Lei T; Li SQ; Mai EH; Ding FH; Niu B
World J Gastroenterol; 2020 Apr; 26(15):1745-1757. PubMed ID: 32351291
[TBL] [Abstract][Full Text] [Related]
8. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
9. Long non‑coding RNA PCED1B‑AS1 promotes pancreatic ductal adenocarcinoma progression by regulating the miR‑411‑3p/HIF‑1α axis.
Zhang Y; Ma H; Chen C
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036383
[TBL] [Abstract][Full Text] [Related]
10. Identification of genes directly regulated by the oncogene ZNF217 using chromatin immunoprecipitation (ChIP)-chip assays.
Krig SR; Jin VX; Bieda MC; O'Geen H; Yaswen P; Green R; Farnham PJ
J Biol Chem; 2007 Mar; 282(13):9703-9712. PubMed ID: 17259635
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression.
Littlepage LE; Adler AS; Kouros-Mehr H; Huang G; Chou J; Krig SR; Griffith OL; Korkola JE; Qu K; Lawson DA; Xue Q; Sternlicht MD; Dijkgraaf GJ; Yaswen P; Rugo HS; Sweeney CA; Collins CC; Gray JW; Chang HY; Werb Z
Cancer Discov; 2012 Jul; 2(7):638-51. PubMed ID: 22728437
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA PART1 predicts a poor prognosis and promotes the malignant progression of pancreatic cancer by sponging miR-122.
Hu X; Zhang L; Tian J; Ma J
World J Surg Oncol; 2021 Apr; 19(1):122. PubMed ID: 33865422
[TBL] [Abstract][Full Text] [Related]
13. Silencing of ZNF217 gene influences the biological behavior of a human ovarian cancer cell line.
Sun G; Zhou J; Yin A; Ding Y; Zhong M
Int J Oncol; 2008 May; 32(5):1065-71. PubMed ID: 18425333
[TBL] [Abstract][Full Text] [Related]
14. NELFE promoted pancreatic cancer metastasis and the epithelial‑to‑mesenchymal transition by decreasing the stabilization of NDRG2 mRNA.
Han L; Zan Y; Huang C; Zhang S
Int J Oncol; 2019 Dec; 55(6):1313-1323. PubMed ID: 31638184
[TBL] [Abstract][Full Text] [Related]
15. LncRNA ZEB1-AS1 promotes pancreatic cancer progression by regulating miR-505-3p/TRIB2 axis.
Wei G; Lu T; Shen J; Wang J
Biochem Biophys Res Commun; 2020 Aug; 528(4):644-649. PubMed ID: 32513531
[TBL] [Abstract][Full Text] [Related]
16. miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1.
Yuan P; Tang C; Chen B; Lei P; Song J; Xin G; Wang Z; Hui Y; Yao W; Wang G; Zhao G
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34468015
[TBL] [Abstract][Full Text] [Related]
17. HOXD9‑induced SCNN1A upregulation promotes pancreatic cancer cell proliferation, migration and predicts prognosis by regulating epithelial‑mesenchymal transformation.
Chang J; Hu X; Nan J; Zhang X; Jin X
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34558641
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
Han Q; Li J; Xiong J; Song Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression.
Yan J; Jia Y; Chen H; Chen W; Zhou X
J Exp Clin Cancer Res; 2019 Sep; 38(1):390. PubMed ID: 31488171
[TBL] [Abstract][Full Text] [Related]
20. The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133a.
Chen B; Li Q; Zhou Y; Wang X; Zhang Q; Wang Y; Zhuang H; Jiang X; Xiong W
Cell Cycle; 2018; 17(16):1949-1966. PubMed ID: 30300116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
